Pharmaceutical SMEs struggle for survival

Experts are now raising concerns that the looming collapse of domestic pharmaceutical firms might in the long run lead to a de-industrialization of the country’s pharmaceutical industry, which faces cutthroat competition with foreign rivals on global markets.

Domestic pharmaceutical small- and medium-size enterprises (SMEs) are feeling a great pinch as the government plans to slash the price...